HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Tough-to-Treat cancers
Disease control CompletedThis study tested a new combination of two immunotherapy drugs (IO102-IO103 and pembrolizumab) as a first treatment for people with advanced lung, head/neck, or bladder cancer that had spread. The goal was to see if the combo could shrink tumors and delay cancer growth. 63 patien…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: IO Biotech • Aim: Disease control
Last updated Apr 29, 2026 01:35 UTC
-
Tumor samples stored to unlock personalized cancer predictions
Knowledge-focused CompletedThis study collected tumor samples from 419 adults with head and neck squamous cell carcinoma to create a biobank. The goal is to use these samples in future research to find genetic clues that can predict how the cancer will respond to treatment. By understanding these factors, …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:36 UTC